FDA approves new drug for type 2 diabetes, a once-a-week injection treatment. The U. S. Food and Drug Administration has approved Tanzeum, a diabetes drug developed as a once-a-week injection treatment for type 2 diabetes, drug maker GlaxoSmithKline has announced.